irreparably damaged by vaccinations. One family at a time, the two mothers discovered they were not alone. And now, through vision, patience, and hard work, PAVE had become a major force, with interest and even some support up to the highest levels of Congress, in addition to tens of thousands of supporting members. The words “Research,” “Education,” and “Choice,” emblazoned on their logo, expressed the agency’s goals.
“We are not a bunch of Carrie Nations charging into immunization centers with axes,” Cheri had explained during Ellen’s first volunteer-orientation session. “But we are tough when we have to be. We will not stop until the powers that be recognize the need for research on the immediate and long-term effects of vaccines, as well as the critical need for public education and ultimately parental choice when it comes to vaccinating our children.”
PAVE had its vehement detractors in the scientific, pediatric, infectious disease, and political arenas, but with each passing year, morbidity statistics; clinical disasters; well-attended, PAVE-sponsored scientific conferences; and parents who experienced what they felt certain was a cause-effect relationship between vaccinations and their children’s disabilities added to the organization’s influence, membership, and war chest.
In the early nineties, the now tax-exempt corporation moved its extensive library, dozens of drawers of case files, seven-person staff, and cadre of committed volunteers to the second floor of a brownstone on 18th Street between DuPont Circle and Adams-Morgan. Following the disaster with Lucy, Ellen had begun to send in modest donations. Later, she took the intensive workshop for volunteers conducted by Cheri and became qualified to man the phones. Then, a year or so after that, word was passed on to PAVE of the establishment of a consumer seat alongside the scientists and physicians on the federal commission evaluating Omnivax.
Ellen was told by Cheri and Sally that, as a retired middle school science teacher without a track record of militancy and confrontation on the vaccine issue, she would be the perfect person for the job. Ultimately, the powers at the FDA agreed. Ellen suspected that those who offered her the appointment were certain either that she would remain relatively silent, or that the scientists and physicians on the panel could easily preempt her views if they had to. Not that it mattered. She was only one vote out of twenty-three, and support for the megavaccine and its thirty components was overwhelming from the start. Even if she opposed the project, which in fact she did, it was clear from the first meeting of the committee that the final tally would stand at twenty-two to one.
The door to the PAVE offices opened into a crowded work area with half a dozen desks, all manned at the moment. As Ellen stepped into the room, the staff on hand rose as one and applauded. She did her best to wave them all back to their seats, then smiled good-naturedly and bowed. Over the past two-plus years, they had all received frequent briefings of the Omnivax sessions, and at times verbatim transcripts. They had all heard stories of how, armed with epidemiological and research data she had painstakingly accumulated, as well as affidavits from experts supporting the PAVE positions, she had stood up to some of the leading proponents of expanding the scope of immunizations. And as often as not, she seemed to have held her own.
“Please, please,” she said, “that’s almost enough applause. You there, a little louder, please. Much better. Now, those of you who desire to, and have washed themselves according to my protocol, may come forward, kneel, and kiss my ring.”
“Hey, where you been?” Sally Lynch called out from the doorway.
“A little trouble with Lucy at school,” Ellen replied. “Nothing serious.”
“Well, Cheri’s late, too, for a change. She’ll be here in a few minutes unless she isn’t. She
Dean Wesley Smith, Kristine Kathryn Rusch
Martin A. Lee, Bruce Shlain